BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22300412)

  • 1. Pityriasis amiantacea: a distinctive presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy.
    Ettler J; Wetter DA; Pittelkow MR
    Clin Exp Dermatol; 2012 Aug; 37(6):639-41. PubMed ID: 22300412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pityriasis amiantacea: a case report.
    Ayanlowo OO; Olowoyo OO; Akinkugbe AO; Adelekan FA; Ahamneze NC
    Niger Postgrad Med J; 2014 Jun; 21(2):196-8. PubMed ID: 25167599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature.
    Osório F; Magro F; Lisboa C; Lopes S; Macedo G; Bettencourt H; Azevedo F; Magina S
    Dermatology; 2012; 225(2):163-7. PubMed ID: 23052429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pityriasis amiantacea and folliculitis decalvans : An unusual manifestation associated with antitumor necrosis factor-α therapy].
    Zamperetti M; Zelger B; Höpfl R
    Hautarzt; 2017 Dec; 68(12):1007-1010. PubMed ID: 29038892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-α inhibitor (adalimumab) induced psoriasis: a case report.
    Al-Mutairi A; Elkashlan M; Al-Fayed HM; Swayed M
    Australas J Dermatol; 2012 May; 53(2):157. PubMed ID: 22571571
    [No Abstract]   [Full Text] [Related]  

  • 6. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.
    Cullen G; Kroshinsky D; Cheifetz AS; Korzenik JR
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1318-27. PubMed ID: 21957906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies.
    Laga AC; Vleugels RA; Qureshi AA; Velazquez EF
    Am J Dermatopathol; 2010 Aug; 32(6):568-73. PubMed ID: 20520526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: three further cases and current overview.
    Pirard D; Arco D; Debrouckere V; Heenen M
    Dermatology; 2006; 213(3):182-6. PubMed ID: 17033165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF-alpha Inhibitors.
    Darrigade AS; Milpied B; Truchetet ME; Schaeverbeke T; Laharie D; Zerbib F; Beylot-Barry M; Jouary T; Taïeb A; Ezzedine K; Seneschal J
    Acta Derm Venereol; 2017 Jun; 97(6):731-734. PubMed ID: 28218339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia.
    Doyle LA; Sperling LC; Baksh S; Lackey J; Thomas B; Vleugels RA; Qureshi AA; Velazquez EF
    Am J Dermatopathol; 2011 Apr; 33(2):161-6. PubMed ID: 21317611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
    Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
    Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis amiantacea.
    Moon CM; Schissel DJ
    Cutis; 1999 Mar; 63(3):169-70. PubMed ID: 10190070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasiform and pustular eruption induced by infliximab.
    Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
    J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
    Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab-induced psoriasis of the scalp with diffuse alopecia: a severe potentially irreversible cutaneous side effect of TNF-alpha blockers.
    El Shabrawi-Caelen L; La Placa M; Vincenzi C; Haidn T; Muellegger R; Tosti A
    Inflamm Bowel Dis; 2010 Feb; 16(2):182-3. PubMed ID: 19462433
    [No Abstract]   [Full Text] [Related]  

  • 16. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
    Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
    J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics.
    Stoffel E; Maier H; Riedl E; Brüggen MC; Reininger B; Schaschinger M; Bangert C; Guenova E; Stingl G; Brunner PM
    Br J Dermatol; 2018 May; 178(5):1151-1162. PubMed ID: 29143979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasiform eruptions during anti TNF-alpha treatment: psoriasis or not?
    Seneschal J; Lepreux S; Milpied B; Schaeverbeke T; Taïeb A
    Arch Dermatol; 2007 Dec; 143(12):1593-5; author reply 1595. PubMed ID: 18087021
    [No Abstract]   [Full Text] [Related]  

  • 19. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions.
    de Gannes GC; Ghoreishi M; Pope J; Russell A; Bell D; Adams S; Shojania K; Martinka M; Dutz JP
    Arch Dermatol; 2007 Feb; 143(2):223-31. PubMed ID: 17310002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scanning electron microscopy of scales from pityriasis amiantacea.
    Batten TL; White MI; Gregory DW
    Acta Derm Venereol; 1993 Oct; 73(5):376-7. PubMed ID: 7904406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.